Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06875206 · ClinicalTrials.gov registry record · NA
Visual Restoration Using Focused Ultrasound Stimulation and Immersive Virtual Reality After Stroke
A NA study, sponsored by Duke University.
- Not yet
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT06875206: Clinical Trial NA study, sponsored by Duke University.
NCT06875206 is a NA study that has not yet begun recruiting, run by Duke University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06875206, a NA study, has not yet begun recruiting, sponsored by Duke University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This research will explore if brain stimulation combined with virtual reality therapy improves visual impairment. The stimulation technique is called low-intensity focused ultrasound stimulation (LIFUS). The treatment uses ultrasound to stimulate vision specific parts of the brain. Before this therapy, the participants will get structural brain imaging. Functional brain imaging will be performed before and after the study's completion to measure brain activity response to therapy. The purpose of this research study is to evaluate patients who have had a stroke between 6 and 24 months ago with a visual field impairment. The duration of active participation in the study is 1.5 months.
Primary Outcome
Change of the blind area in the visual fields as measured by visual perimetry implemented in a virtual reality (VR) headset
Interventions
- DEVICE Low-intensity focused ultrasound
- DEVICE Immersive virtual reality
- DEVICE Inactive Low-intensity focused ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2026-12-01 |
| Est. Completion | 2027-04 |
| Phase | NA |
What is known before NCT06875206 opens enrollment
NCT06875206 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Low-intensity focused ultrasound is the first listed.
NCT06875206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06875206 about?
NCT06875206 is a clinical study titled "Visual Restoration Using Focused Ultrasound Stimulation and Immersive Virtual Reality After Stroke". This research will explore if brain stimulation combined with virtual reality therapy improves visual impairment. The stimulation technique is called low-intensity focused ultrasound stimulation (LIFUS). The treatment uses ultrasound to stimulate vision specific parts of the brain. Before this thera...
What is the current status of trial NCT06875206?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2026-12-01. Estimated completion is 2027-04.
What interventions are being tested in trial NCT06875206?
The interventions under investigation include: Low-intensity focused ultrasound (DEVICE), Immersive virtual reality (DEVICE), Inactive Low-intensity focused ultrasound (DEVICE).
Who is sponsoring clinical trial NCT06875206?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06875206's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI